B Lymphocyte Chemoattractant (CXCL13) Is an Indicator of Acute Gastrointestinal GVHD in Murine Model

[1]  Deepika Singh,et al.  Analysis of CXCR5+Th17 cells in relation to disease activity and TNF inhibitor therapy in Rheumatoid Arthritis , 2016, Scientific Reports.

[2]  C. Doglioni,et al.  IL‐17 superfamily cytokines modulate normal germinal center B cell migration , 2016, Journal of leukocyte biology.

[3]  N. Câmara,et al.  Follicular helper T cell in immunity and autoimmunity , 2016, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[4]  T. Brümmendorf,et al.  Telomere shortening in enterocytes of patients with uncontrolled acute intestinal graft-versus-host disease. , 2015, Blood.

[5]  B. Storer,et al.  Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment. , 2015, Blood.

[6]  A. Jonason,et al.  CXCL13 antibody for the treatment of autoimmune disorders , 2015, BMC Immunology.

[7]  A. Wåhlin,et al.  Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation , 2015, Scientific Reports.

[8]  M. Troxell,et al.  Hematopoietic Stem Cell Transplantation: Graft Versus Host Disease and Pathology of Gastrointestinal Tract, Liver, and Lung , 2014, Advances in anatomic pathology.

[9]  T. Cheng,et al.  Graft-versus-host disease causes broad suppression of hematopoietic primitive cells and blocks megakaryocyte differentiation in a murine model. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  Yuqi Sun,et al.  Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice. , 2014, Cytokine.

[11]  J. Bolaños-Meade,et al.  Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. , 2012, Blood.

[12]  Kailin Xu,et al.  Altered balance between Th1 and Th17 cells in circulation is an indicator for the severity of murine acute GVHD. , 2012, Immunology letters.

[13]  M. Horowitz,et al.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation. , 2012, Blood.

[14]  Thomas M Braun,et al.  Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. , 2011, Blood.

[15]  Xiangyu Zhao,et al.  Characterization of CD3+CD4-CD8- (double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation. , 2011, Transplant immunology.

[16]  J. Dipersio,et al.  Mouse models of graft-versus-host disease: advances and limitations , 2011, Disease Models & Mechanisms.

[17]  Y. Matsuno,et al.  Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. , 2010, Blood.

[18]  M. Haubitz,et al.  B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  J. Ritz,et al.  Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. , 2009, Blood.

[20]  Thomas M Braun,et al.  A biomarker panel for acute graft-versus-host disease. , 2009, Blood.

[21]  J. Parfitt,et al.  Mycophenolate Mofetil-related Gastrointestinal Mucosal Injury: Variable Injury Patterns, Including Graft-versus-Host Disease-like Changes , 2008, The American journal of surgical pathology.

[22]  H. Tsutsumi,et al.  CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease. , 2008, Blood.

[23]  M. Görner,et al.  Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. , 2006, Blood.

[24]  Li Zhang,et al.  CXCR5/CXCL13 Interaction Is Important for Double-Negative Regulatory T Cell Homing to Cardiac Allografts1 , 2006, The Journal of Immunology.

[25]  U. Panzer,et al.  BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. , 2005, Kidney international.

[26]  A. Ogata,et al.  Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells. , 1999, Cellular immunology.

[27]  D. Batinić,et al.  Pre-treatment of transplant bone marrow cells with hydrocortisone and cyclosporin A alleviates graft-versus-host reaction in a murine allogeneic host–donor combination , 1999, Bone Marrow Transplantation.

[28]  J. Crawford,et al.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. , 1997, Blood.

[29]  Snover Dc.  Mucosal damage simulating acute graft-versus-host reaction in cytomegalovirus colitis. , 1985 .

[30]  E. Holler,et al.  Graft-versus-host disease , 2009, The Lancet.

[31]  X. N. Wang,et al.  Identification and validation of biomarkers associated with acute and chronic graft versus host disease , 2016, Bone Marrow Transplantation.

[32]  T. Braun,et al.  A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study. , 2015, The Lancet. Haematology.

[33]  J. Ritz,et al.  B cells in chronic graft-versus-host disease. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[34]  J. Ritz,et al.  Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans. , 2012, Blood.

[35]  P. Chevallier,et al.  Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[36]  D. Snover.  Mucosal damage simulating acute graft-versus-host reaction in cytomegalovirus colitis. , 1985, Transplantation.